News

Therapeutic innovations are as diverse as the challenges they address—ranging from gene and cell therapies to mRNA-based treatments and next-generation biologics.

mRNA technology has emerged as a transformative force in the biopharmaceutical industry, enabling groundbreaking therapies and vaccines, including those for COVID-19.

Advanced therapies, particularly cell and gene therapies, are ushering in a new era of personalized medicine, offering hope for patients with previously untreatable diseases.

What is the perfect recipe that delivers the maximum result?

What is the perfect recipe that delivers the maximum result?

Working in a Biotech Manufacturing Organization means joining a team of talented professionals focused on innovation, continuous growth, and a shared mission to improve lives.

Anemocyte offers plasmid DNA (pDNA) manufacturing covering R&D, High Quality and GMP needs providing solutions that support every stage of therapy development while ensuring rigorous quality and traceability.

Quality assurance (QA) is crucial in the manufacturing of plasmid DNA (pDNA), a key component in gene therapy, vaccine development, genome editing, and synthetic biology.

Discover the pivotal role of plasmid DNA sequencing in advancing gene therapy. Learn how this groundbreaking technology is driving the development of novel treatments and shaping the future of biomedicine.

Downstream process is fine tuned to recover the soluble fraction of plasmidic DNA, whereas the genomic DNA, proteins polysaccharides and total RNA from E. coli cells are precipitated and removed by depth filtration.